
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.370 | 2.670 | 0.300 |
Shares | 97.630 | 97.630 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.713 | 17.876 |
Price to Book | 3.808 | 3.691 |
Price to Sales | 6.001 | 5.266 |
Price to Cash Flow | 16.828 | 13.963 |
Dividend Yield | 0.756 | 0.521 |
5 Years Earnings Growth | 42.967 | 16.281 |
Number of long holdings: 52
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.90 | 485.89 | -2.92% | |
Alnylam | US02043Q1076 | 6.54 | 230.50 | -0.19% | |
AbbVie | US00287Y1091 | 5.52 | 171.68 | -2.90% | |
Neurocrine | US64125C1099 | 5.32 | 100.10 | +4.10% | |
Gilead | US3755581036 | 5.24 | 104.88 | -0.76% | |
Guardant Health | US40131M1099 | 4.68 | 45.18 | +0.74% | |
Amgen | US0311621009 | 4.32 | 282.64 | -4.29% | |
Royalty Pharma | GB00BMVP7Y09 | 3.28 | 32.19 | -0.80% | |
Roivant Sciences Ltd Ordinary Shares | - | 3.19 | - | - | |
BioNTech | US09075V1026 | 2.98 | 98.25 | -0.76% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.21B | 0.28 | -0.90 | 4.85 | ||
LU1300848345 | 6.21B | 0.33 | -0.60 | - | ||
LU1323611266 | 3.78B | 4.34 | 0.23 | - | ||
LU1520716801 | 3.78B | 7.31 | 2.63 | - | ||
UBS luxEqSICAV USA Growth USD P Acc | 2.64B | 30.57 | 6.64 | 13.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review